Helius Medical Technologies is trading 8.19% down at $2.08, with no confirmed company-specific catalyst for the decline.
- Available search results show no confirmed company-specific announcement or credible report published on October 30 explaining the decline.
- The investor-relations page lists an October 22 announcement about its Hong Kong designation, not a new event for October 30.
- Healthcare is reported up 2.32%, opposite the stock’s direction. With no clear catalyst or reported volume data, the move’s cause remains unconfirmed.